Market Access

Market Access

PharmaRelations picnic 2022 8

Market Access

To succeed with market access in the Nordic region proactivity and resilience are needed. Market access considerations need to be implemented already when compounds are planned for phase 3 studies, throughout the regulatory process, and finetuned until submission for price and reimbursement and finally for implementation decisions and budget allocations.


Our consultants have solid backgrounds in the various fields of Market Access, and if additional expertise is needed, we partner up with the right specialists across the Nordics, all based on your aspiration with the product.



The consultancy solution may be long-term or short-term, full-time or part-time, or single or multiple consultant approaches. We can offer solutions that cover only one or several Nordic countries. We believe in creating long-term value for your assets and prefer working in partnership, but also take on smaller projects, solve peak capacity problems, and help you with ad-hoc projects within the Market Access fields.

Services

Nordic Market Access Strategy:

  • Market access insight into the clinical program to secure success in HTA assessments/market access (national/regional), ie after regulatory approval.
  • Development and tailoring of the market access strategy according to the therapeutic area, business potential, and company resources.
  • Map current market access situation, risks, and opportunities for new products when entering a new therapeutic area and/or new market.
  • Development and tailoring of  “product-market fit” and “go-2-market strategy”.
  • Stress-test/validate your own “go-2-market strategy”.


Reimbursement submissions in Nordics:

  • Adaptation and/or development of reimbursement dossiers
  • Advisory Boards (Medical/Market access)
  • Cost-effectiveness, cost-utility, cost-benefit, budget impact, value tools
  • Submission of P&R dossier and support during the assessment period


Price & tender:

  • Validating Global pricing surveys/strategy
  • Support during the negotiation process at national/regional levels.
  • Support with regional stakeholder mapping and execution of regional activities.
  • Strategic and tactical handling of tenders/procurement
  • Regular Price updates


Market Access training

  • Training sessions that provide an in-depth of the market access landscape and recent developments.
  • Tailored training sessions for specific therapeutic areas or purposes


Other services:

  • Development of Global Value Dossier (GVD) and Value story
  • Proof of concept of RWE studies and protocol development

This website use cookiesfor statistic and user experience.

Pharmarelations uses cookies to improve your user experience, to give basis for improvement and further development of the website and to be able to direct more relevant offers to you. Please read our personal data policy. If you agree to our use, select Allow All. If you want to change your choice afterwards, you will find that option at the bottom of the page.

Cookies